Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vrinda Kulkarni

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of Parasitology|February 9, 2018
An uncommon manifestation of a common diseaseGiselle Dsilva, Vrinda Kulkarni, Sangeeta Aher
Blood Cells, Molecules & Diseases|February 3, 2012
Separation of young and mature thrombocytes by a novel immuno-selection methodVrinda Kulkarni, Seongcheol Kim, Lala Zafreen, et al.
Plos One|December 29, 2009
Evolution of primary hemostasis in early vertebratesSeongcheol Kim, Maira Carrillo, Vrinda Kulkarni, et al.
Indian Journal of Pharmacology|October 2, 2019
Methylenetetrahydrofolate reductase polymorphism in healthy volunteers and its correlation with homocysteine levels in patients with thrombosisRenuka Munshi, Falguni Panchal, Vrinda Kulkarni, et al.
Blood Cells, Molecules & Diseases|November 2, 2010
Zebrafish von Willebrand factorMaira Carrillo, Seongcheol Kim, Surendra Kumar Rajpurohit, et al.
Blood Cells, Molecules & Diseases|January 5, 2010
Vivo-Morpholino knockdown of alphaIIb: A novel approach to inhibit thrombocyte function in adult zebrafishSeongcheol Kim, Uvaraj P Radhakrishnan, Surendra Kumar Rajpurohit, et al.
European Journal of Pharmacology|April 23, 2013
Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin dosage, over anticoagulation and other adverse outcomes in Indian populationTejasvita Gaikwad, Kanjaksha Ghosh, Bipin Kulkarni, et al.
The Journal of the Association of Physicians of India|April 30, 2014
Refractory anaemia in an immunocompromised patient--what is it?Dhiraj Bhattad, Vrinda Kulkarni, Abhay Bhave, et al.
The Journal of the Association of Physicians of India|May 14, 2014
Warfarin therapy--why one dose does not fit all!Vrinda Kulkarni, Abhay Bhave, Renuka Kulkarni Munshi, et al.
Nuclear Medicine Communications|July 8, 2024
Internal dosimetry and biodistribution of indigenously prepared 177 Lu-DOTA-rituximab in lymphoma and other hematological malignancies treated with rituximabYeshwanth Edamadaka, Rahul V Parghane, Sudeep Sahu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of Parasitology|February 9, 2018
An uncommon manifestation of a common diseaseGiselle Dsilva, Vrinda Kulkarni, Sangeeta Aher
Blood Cells, Molecules & Diseases|February 3, 2012
Separation of young and mature thrombocytes by a novel immuno-selection methodVrinda Kulkarni, Seongcheol Kim, Lala Zafreen, et al.
Plos One|December 29, 2009
Evolution of primary hemostasis in early vertebratesSeongcheol Kim, Maira Carrillo, Vrinda Kulkarni, et al.
Indian Journal of Pharmacology|October 2, 2019
Methylenetetrahydrofolate reductase polymorphism in healthy volunteers and its correlation with homocysteine levels in patients with thrombosisRenuka Munshi, Falguni Panchal, Vrinda Kulkarni, et al.
Blood Cells, Molecules & Diseases|November 2, 2010
Zebrafish von Willebrand factorMaira Carrillo, Seongcheol Kim, Surendra Kumar Rajpurohit, et al.
Blood Cells, Molecules & Diseases|January 5, 2010
Vivo-Morpholino knockdown of alphaIIb: A novel approach to inhibit thrombocyte function in adult zebrafishSeongcheol Kim, Uvaraj P Radhakrishnan, Surendra Kumar Rajpurohit, et al.
European Journal of Pharmacology|April 23, 2013
Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin dosage, over anticoagulation and other adverse outcomes in Indian populationTejasvita Gaikwad, Kanjaksha Ghosh, Bipin Kulkarni, et al.
The Journal of the Association of Physicians of India|April 30, 2014
Refractory anaemia in an immunocompromised patient--what is it?Dhiraj Bhattad, Vrinda Kulkarni, Abhay Bhave, et al.
The Journal of the Association of Physicians of India|May 14, 2014
Warfarin therapy--why one dose does not fit all!Vrinda Kulkarni, Abhay Bhave, Renuka Kulkarni Munshi, et al.
Nuclear Medicine Communications|July 8, 2024
Internal dosimetry and biodistribution of indigenously prepared 177 Lu-DOTA-rituximab in lymphoma and other hematological malignancies treated with rituximabYeshwanth Edamadaka, Rahul V Parghane, Sudeep Sahu, et al.
Pageof 1